Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide a webcast of their corporate presentation at JMP Securities Healthcare Conference at 12:30 PM (ET) on Wednesday, July 10, 2013 in New York.
The webcast may be accessed under " Webcasts" in the Investor Relations section of the Company's website. The webcast can be accessed live and will be available for replay after the presentation on the Company's website.
Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® system product family.